<html><head><meta name="qrichtext" content="charset=utf-8" /></head><body style="font-size:10pt;font-family:Sans">
<p>&nbsp;<br /><br /><br /></p>
<p align="center"><span style="font-weight:600">LA&nbsp;DOULEUR</span><br /></p>
<p>La<span style="font-weight:600">&nbsp;</span>douleur<span style="font-weight:600">&nbsp;</span>est<span style="font-weight:600">&nbsp;</span>un<span style="font-weight:600">&nbsp;</span>symptome<span style="font-weight:600">&nbsp;</span>subjectif.<span style="font-weight:600">&nbsp;</span>II<span style="font-weight:600">&nbsp;</span>est<span style="font-weight:600">&nbsp;</span>impossible<span style="font-weight:600">&nbsp;</span>de<span style="font-weight:600">&nbsp;</span>juger<span style="font-weight:600">&nbsp;</span>de<span style="font-weight:600">&nbsp;</span>la<span style="font-weight:600">&nbsp;</span>réalité<span style="font-weight:600">&nbsp;</span>et<span style="font-weight:600">&nbsp;</span>de<span style="font-weight:600">&nbsp;</span>I'intensité<span style="font-weight:600">&nbsp;</span>de<span style="font-weight:600">&nbsp;</span>la&nbsp;douleur<span style="font-weight:600">&nbsp;</span>d'un<span style="font-weight:600">&nbsp;</span>patient.<span style="font-weight:600">&nbsp;La&nbsp;douleur&nbsp;est&nbsp;une&nbsp;urgence&nbsp;médicale&nbsp;et&nbsp;doit&nbsp;prise&nbsp;en&nbsp;charge&nbsp;comme&nbsp;telle.<br /><br /></span><span style="font-weight:600;text-decoration:underline">1/&nbsp;COMMENCER&nbsp;PAR&nbsp;:</span><br /><span style="font-weight:600">&nbsp;	Rechercher&nbsp;la&nbsp;douleur&nbsp;</span>:&quot;Avez-vous<span style="font-weight:600">&nbsp;</span>mal<span style="font-weight:600">&nbsp;</span>quelque<span style="font-weight:600">&nbsp;</span>part?&quot;<span style="font-weight:600">&nbsp;</span>est<span style="font-weight:600">&nbsp;</span>une<span style="font-weight:600">&nbsp;</span>question<span style="font-weight:600">&nbsp;</span>à&nbsp;poser<span style="font-weight:600">&nbsp;</span>à<br />					TOUS<span style="font-weight:600">&nbsp;</span>les<span style="font-weight:600">&nbsp;</span>patients<span style="font-weight:600">&nbsp;</span>dès<span style="font-weight:600">&nbsp;</span>le<span style="font-weight:600">&nbsp;</span>début<span style="font-weight:600">&nbsp;</span>de<span style="font-weight:600">&nbsp;</span>I'entretien.<br /><span style="font-weight:600">	Evaluer&nbsp;la&nbsp;douleur&nbsp;</span>:&nbsp;la<span style="font-weight:600">&nbsp;</span>quantification<span style="font-weight:600">&nbsp;</span>s'effectue<span style="font-weight:600">&nbsp;</span>grâce<span style="font-weight:600">&nbsp;</span>à&nbsp;IEchelle&nbsp;visuelle&nbsp;				Analogique.<br /><span style="font-weight:600;text-decoration:underline">2/&nbsp;PUIS&nbsp;TRAITER&nbsp;:</span><br /><span style="font-weight:600">	Penser&nbsp;au&nbsp;traitement&nbsp;Etiologique&nbsp;</span>:&nbsp;immobilisation<span style="font-weight:600">&nbsp;</span>d'une<span style="font-weight:600">&nbsp;</span>fracture,<span style="font-weight:600">&nbsp;</span>reperfusion<span style="font-weight:600">&nbsp;				</span>d'une<span style="font-weight:600">&nbsp;</span>zone&nbsp;ischémique,<span style="font-weight:600">&nbsp;</span>traitement<span style="font-weight:600">&nbsp;</span>chinrrgical<span style="font-weight:600">&nbsp;</span>d'un<span style="font-weight:600">&nbsp;</span>abcès...<br /><span style="font-weight:600">	Le&nbsp;traitement&nbsp;symptomatique&nbsp;:</span>il&nbsp;doit&nbsp;être&nbsp;ANNONCE&nbsp;au&nbsp;patient.<br /><br /></p>
<p align="center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;LE&nbsp;TRAITEMENT&nbsp;SYMPTOMATIQUE<br />	L'OMS<span style="font-weight:600">&nbsp;</span>a&nbsp;classé<span style="font-weight:600">&nbsp;</span>les<span style="font-weight:600">&nbsp;</span>antalgiques<span style="font-weight:600">&nbsp;</span>en<span style="font-weight:600">&nbsp;</span>3&nbsp;paliers<span style="font-weight:600">&nbsp;</span>:<br /></p>
<p>	<span style="font-weight:600">Palier&nbsp;I</span>&nbsp;&nbsp;=&nbsp;les<span style="font-weight:600">&nbsp;</span>antalgiques<span style="font-weight:600">&nbsp;</span>&quot;périphériques&quot;<span style="font-weight:600">&nbsp;</span>:&nbsp;	<span style="font-weight:600">Paracétamol</span>,<span style="font-weight:600">&nbsp;Aspirine</span>,<span style="font-weight:600">&nbsp;AINS</span><br />	<span style="font-weight:600">Palier&nbsp;II&nbsp;</span>=&nbsp;les<span style="font-weight:600">&nbsp;</span>morphiniques<span style="font-weight:600">&nbsp;</span>faibles<span style="font-weight:600">&nbsp;</span>:		<span style="font-weight:600">Tramadol&nbsp;</span>(Topalgic*,<span style="font-weight:600">&nbsp;</span>Contramal'),<span style="font-weight:600">&nbsp;<br />								Codéine</span>,&nbsp;<span style="font-weight:600">Dextropropoxiphéne</span><br />	<span style="font-weight:600">Palier&nbsp;III</span>=<span style="font-weight:600">&nbsp;</span>les<span style="font-weight:600">&nbsp;</span>morphiniques<span style="font-weight:600">&nbsp;</span>forts<span style="font-weight:600">&nbsp;</span>:&nbsp;			<span style="font-weight:600">Nubain</span>,<span style="font-weight:600">&nbsp;Morphine</span><br />Le<span style="font-weight:600">&nbsp;</span>paracétamol<span style="font-weight:600">&nbsp;</span>peut<span style="font-weight:600">&nbsp;</span>étre<span style="font-weight:600">&nbsp;</span>associé<span style="font-weight:600">&nbsp;</span>avec<span style="font-weight:600">&nbsp;</span>les<span style="font-weight:600">&nbsp;</span>AINS<span style="font-weight:600">&nbsp;</span>et<span style="font-weight:600">&nbsp;</span><span style="font-style:italic">I&nbsp;</span>ou<span style="font-weight:600">&nbsp;</span>les<span style="font-weight:600">&nbsp;</span>morphiniques<span style="font-weight:600">&nbsp;</span>faibles<span style="font-weight:600">&nbsp;</span>ou<span style="font-weight:600">&nbsp;</span>forts<span style="font-weight:600">&nbsp;</span>selon<span style="font-weight:600">&nbsp;</span>les&nbsp;cas.<br />Attention<span style="font-weight:600">&nbsp;</span>g&nbsp;I'association<span style="font-weight:600">&nbsp;</span>de<span style="font-weight:600">&nbsp;</span>2&nbsp;morphiniques<span style="font-weight:600">&nbsp;</span>car<span style="font-weight:600">&nbsp;</span>effets<span style="font-weight:600">&nbsp;</span>secondaires<span style="font-weight:600">&nbsp;</span>identiques<span style="font-weight:600">&nbsp;</span>donc<span style="font-weight:600">&nbsp;</span>additifs!<br /><span style="font-weight:600;text-decoration:underline">I&nbsp;Les&nbsp;antalgiques&nbsp;&quot;périphériques&quot;</span><br />	1)<span style="font-weight:600">&nbsp;Le&nbsp;Paracétamol&nbsp;IV</span>&nbsp;=<span style="font-weight:600">&nbsp;</span>PRODAFALGAN<span style="font-weight:600">&nbsp;</span>:29<span style="font-weight:600">&nbsp;</span>=lg<span style="font-weight:600">&nbsp;</span>de<span style="font-weight:600">&nbsp;</span>Paracétamol<br /><span style="font-weight:600">		Utilisation&nbsp;</span>:&nbsp;1&nbsp;ampoule<span style="font-weight:600">&nbsp;</span>de<span style="font-weight:600">&nbsp;</span>29<span style="font-weight:600">&nbsp;</span>en<span style="font-weight:600">&nbsp;</span>flash<span style="font-weight:600">&nbsp;</span>de<span style="font-weight:600">&nbsp;</span>15<span style="font-weight:600">&nbsp;</span>mn<span style="font-weight:600">&nbsp;</span>dans<span style="font-weight:600">&nbsp;</span>100cc<span style="font-weight:600">&nbsp;</span>G5<span style="font-weight:600">&nbsp;</span>ou<span style="font-weight:600">&nbsp;</span>sérum<span style="font-weight:600">&nbsp;				</span>phy<span style="font-weight:600">&nbsp;</span>après<span style="font-weight:600">&nbsp;</span>dilution<span style="font-weight:600">&nbsp;</span>dans&nbsp;le<span style="font-weight:600">&nbsp;</span>solvant<span style="font-weight:600">&nbsp;</span>d'origine.<span style="font-weight:600">&nbsp;</span>Efficace<span style="font-weight:600">&nbsp;</span>en<span style="font-weight:600">&nbsp;</span>10<span style="font-weight:600">&nbsp;</span>à&nbsp;15<span style="font-weight:600">&nbsp;				</span>mn<span style="font-weight:600">&nbsp;</span>pour<span style="font-weight:600">&nbsp;</span>4&nbsp;heures.<span style="font-weight:600">&nbsp;</span>Posologie<span style="font-weight:600">&nbsp;</span>max<span style="font-weight:600">&nbsp;</span>=&nbsp;6&nbsp;à&nbsp;8g<span style="font-weight:600">&nbsp;</span>/&nbsp;24h.<br /><span style="font-weight:600">		Indications&nbsp;</span>:&nbsp;tous<span style="font-weight:600">&nbsp;</span>les<span style="font-weight:600">&nbsp;</span>types<span style="font-weight:600">&nbsp;</span>de<span style="font-weight:600">&nbsp;</span>douleurs.<span style="font-weight:600">&nbsp;<br />		Contre&nbsp;indications&nbsp;</span>:&nbsp;Insuffisance<span style="font-weight:600">&nbsp;</span>hépato<span style="font-weight:600">&nbsp;</span>cellulaire,&nbsp;allergie,<span style="font-weight:600">&nbsp;</span>enfant<span style="font-weight:600">&nbsp;</span>&lt;&nbsp;15<span style="font-weight:600">&nbsp;</span>ans<span style="font-weight:600">&nbsp;					</span>(2g)<span style="font-weight:600">&nbsp;<br />		Effets&nbsp;secondaires</span>:<span style="font-weight:600">&nbsp;</span>(rares)<span style="font-weight:600">&nbsp;</span>allergies,<span style="font-weight:600">&nbsp;</span>hépatotoxicité.<span style="font-weight:600">&nbsp;</span>Utilisable<span style="font-weight:600">&nbsp;</span>chez<span style="font-weight:600">&nbsp;</span>la<br />					femme&nbsp;enceinte.<br />	<span style="font-weight:600">2)&nbsp;Per&nbsp;os&nbsp;=&nbsp;DAFALGAN&nbsp;et&nbsp;DOLIPRANE&nbsp;</span>:&nbsp;Efficace<span style="font-weight:600">&nbsp;</span>en<span style="font-weight:600">&nbsp;</span>30<span style="font-weight:600">&nbsp;</span>mn<span style="font-weight:600">&nbsp;</span>pour<span style="font-weight:600">&nbsp;</span>4&nbsp;heures.<span style="font-weight:600">&nbsp;				</span>Donner<span style="font-weight:600">&nbsp;</span>1g&nbsp;d'emblée.<span style="font-weight:600">&nbsp;</span>Posologie<span style="font-weight:600">&nbsp;</span>max<span style="font-weight:600">&nbsp;</span>=&nbsp;3&nbsp;à&nbsp;4g<span style="font-weight:600">&nbsp;/</span><span style="font-style:italic">&nbsp;</span>24h<br />	<span style="font-weight:600">3)&nbsp;Les&nbsp;AINS&nbsp;:&nbsp;PROFENID</span><br /><span style="font-weight:600">		Utilisatlon&nbsp;</span>:&nbsp;1&nbsp;ampoule<span style="font-weight:600">&nbsp;</span>en<span style="font-weight:600">&nbsp;</span>flash<span style="font-weight:600">&nbsp;</span>de<span style="font-weight:600">&nbsp;</span>15<span style="font-weight:600">&nbsp;</span>mn<span style="font-weight:600">&nbsp;</span>dans<span style="font-weight:600">&nbsp;</span>100cc<span style="font-weight:600">&nbsp;</span>G5<span style="font-weight:600">&nbsp;</span>ou<span style="font-weight:600">&nbsp;</span>sérum<span style="font-weight:600">&nbsp;</span>physio<span style="font-weight:600">&nbsp;				</span>(attention<span style="font-weight:600">&nbsp;</span>à&nbsp;ne<span style="font-weight:600">&nbsp;</span>pas&nbsp;utiliser<span style="font-weight:600">&nbsp;</span>le<span style="font-weight:600">&nbsp;</span>solvant<span style="font-weight:600">&nbsp;</span>pour<span style="font-weight:600">&nbsp;</span>IM).<span style="font-weight:600">&nbsp;</span>Renouvelable<span style="font-weight:600">&nbsp;</span>8&nbsp;				heures<span style="font-weight:600">&nbsp;</span>après.<span style="font-weight:600">&nbsp;<br />		Indications&nbsp;</span>:colique<span style="font-weight:600">&nbsp;</span>néphrétique,&nbsp;colique<span style="font-weight:600">&nbsp;</span>hépatique,<span style="font-weight:600">&nbsp;</span>dysménorrhée,<span style="font-weight:600">&nbsp;</span>algies<span style="font-weight:600">&nbsp;				</span>dentaires,<span style="font-weight:600">&nbsp;</span>douleurs<span style="font-weight:600">&nbsp;</span>pleurales,<span style="font-weight:600">&nbsp;</span>sciatiques,<span style="font-weight:600">&nbsp;</span>traumatismes,<br />				crise<span style="font-weight:600">&nbsp;</span>drépanocytaire...<span style="font-weight:600">&nbsp;<br />		Contre&nbsp;indications&nbsp;</span>:&nbsp;Allergie<span style="font-weight:600">&nbsp;</span>AINS<span style="font-weight:600">&nbsp;</span>et<span style="font-weight:600">&nbsp;</span>Aspirine,<span style="font-weight:600">&nbsp;</span>Ulcère<span style="font-weight:600">&nbsp;</span>évolutif,<span style="font-weight:600">&nbsp;</span>Grossesse,<br />				hypovolémie,<span style="font-weight:600">&nbsp;</span>Insuffisance<span style="font-weight:600">&nbsp;</span>hépato<span style="font-weight:600">&nbsp;</span>cellulaire<span style="font-weight:600">&nbsp;</span>ou<span style="font-weight:600">&nbsp;</span>rénale<span style="font-weight:600">&nbsp;</span>grave,<span style="font-weight:600">&nbsp;				</span>enfant<span style="font-weight:600">&nbsp;</span>&lt;&nbsp;15<span style="font-weight:600">&nbsp;</span>ans<br />	<span style="font-weight:600">4)&nbsp;L'ASPIRINE&nbsp;:&nbsp;</span>n'a<span style="font-weight:600">&nbsp;</span>pas<span style="font-weight:600">&nbsp;</span>sa<span style="font-weight:600">&nbsp;</span>place<span style="font-weight:600">&nbsp;</span>au<span style="font-weight:600">&nbsp;</span>SAU<span style="font-weight:600">&nbsp;</span>pour<span style="font-weight:600">&nbsp;</span>le<span style="font-weight:600">&nbsp;</span>traitement<span style="font-weight:600">&nbsp;</span>de<span style="font-weight:600">&nbsp;</span>la<span style="font-weight:600">&nbsp;</span>douleur.<br />	<span style="font-weight:600">5)&nbsp;LES&nbsp;PRODUITS&nbsp;INTERDITS&nbsp;:Noramidopyrine&nbsp;et&nbsp;tous&nbsp;ses&nbsp;dérivés<br /></span><br /><span style="font-weight:600;text-decoration:underline">II&nbsp;&nbsp;Les&nbsp;&nbsp;morphiniques&nbsp;&nbsp;faibles</span><br /><span style="font-weight:600">	1)&nbsp;Topalgic&nbsp;</span>:&nbsp;En<span style="font-weight:600">&nbsp;</span>IV<span style="font-weight:600">&nbsp;</span>100<span style="font-weight:600">&nbsp;</span>mg<span style="font-weight:600">&nbsp;</span>en<span style="font-weight:600">&nbsp;</span>flash.<span style="font-weight:600">&nbsp;</span>Attention<span style="font-weight:600">&nbsp;</span>aux<span style="font-weight:600">&nbsp;</span>nausées<span style="font-weight:600">&nbsp;=&gt;&nbsp;</span>Primpéran<span style="font-weight:600">&nbsp;</span>au<span style="font-weight:600">&nbsp;		</span>besoin&nbsp;	Per<span style="font-weight:600">&nbsp;</span>os<span style="font-weight:600">&nbsp;</span>Topalgic<span style="font-weight:600">&nbsp;</span>50<span style="font-weight:600">&nbsp;</span>mg<span style="font-weight:600">&nbsp;</span>préférer<span style="font-weight:600">&nbsp;</span>ensuae<span style="font-weight:600">&nbsp;</span>la<span style="font-weight:600">&nbsp;</span>forme<span style="font-weight:600">&nbsp;</span>LP<span style="font-weight:600">&nbsp;</span>Topalgic<span style="font-weight:600">&nbsp;</span>ou<span style="font-weight:600">&nbsp;				</span>Contramal<span style="font-weight:600">&nbsp;</span>LP<span style="font-weight:600">&nbsp;</span>50,<span style="font-weight:600">&nbsp;</span>100<span style="font-weight:600">&nbsp;</span>ou<span style="font-weight:600">&nbsp;</span>200&nbsp;mg&nbsp;matin<span style="font-weight:600">&nbsp;</span>et<span style="font-weight:600">&nbsp;</span>soir.<br /><span style="font-weight:600">	2)&nbsp;Assoclations&nbsp;de&nbsp;paracétamol&nbsp;et&nbsp;de&nbsp;morphiniques&nbsp;faibles&nbsp;</span>:&nbsp;Propofan,<span style="font-weight:600">&nbsp;<br />		</span>Di-antalvic,&nbsp;Efferalgan<span style="font-weight:600">&nbsp;</span>codéine,<span style="font-weight:600">&nbsp;</span>Dafalgan<span style="font-weight:600">&nbsp;</span>codéiné,Codoliprane<span style="font-weight:600">&nbsp;</span>:&nbsp;1&nbsp;à&nbsp;2&nbsp;		comprimés<span style="font-weight:600">&nbsp;</span>jusqu'à<span style="font-weight:600">&nbsp;</span>6cp<span style="font-weight:600">&nbsp;/</span><span style="font-style:italic">&nbsp;</span>24<span style="font-weight:600">&nbsp;</span>h&nbsp;(CI<span style="font-weight:600">&nbsp;</span>âge<span style="font-weight:600">&nbsp;</span>&lt;&nbsp;15&nbsp;ans)<br /><br /><span style="font-weight:600;text-decoration:underline">III&nbsp;Les&nbsp;&nbsp;morphiniques&nbsp;forts&nbsp;</span>:&nbsp;Préférer<span style="font-weight:600">&nbsp;</span>la<span style="font-weight:600">&nbsp;</span>Morphine<span style="font-weight:600">&nbsp;</span>au<span style="font-weight:600">&nbsp;</span>Nubain<span style="font-weight:600">&nbsp;</span>(cf<span style="font-weight:600">&nbsp;</span>fiche<span style="font-weight:600">&nbsp;</span>MORPHINE)<br /><br /><span style="font-weight:600;text-decoration:underline">IV&nbsp;Traitements&nbsp;adiuvants</span><br /><span style="font-weight:600">	1)&nbsp;Les&nbsp;anxiolytiques&nbsp;</span>:jamais<span style="font-weight:600">&nbsp;</span>seuls<span style="font-weight:600">&nbsp;</span>pour<span style="font-weight:600">&nbsp;</span>traiter<span style="font-weight:600">&nbsp;</span>la<span style="font-weight:600">&nbsp;</span>douleur.<span style="font-weight:600">&nbsp;</span>Efficaces<span style="font-weight:600">&nbsp;</span>en<span style="font-weight:600">&nbsp;</span>association.<br /><span style="font-weight:600">	2)&nbsp;Les&nbsp;antispasmodiques&nbsp;</span>:&nbsp;Spasfon<span style="font-weight:600">&nbsp;</span>2&nbsp;Amp<span style="font-weight:600">&nbsp;</span>IV<span style="font-weight:600">&nbsp;</span>ou<span style="font-weight:600">&nbsp;</span>6&nbsp;Amp<span style="font-weight:600">&nbsp;</span>flash.<span style="font-weight:600">&nbsp;</span>Pas<span style="font-weight:600">&nbsp;</span>d'effet<span style="font-weight:600">&nbsp;			</span>antalgique<span style="font-weight:600">&nbsp;</span>vrai.&nbsp;Semblent<span style="font-weight:600">&nbsp;</span>utiles<span style="font-weight:600">&nbsp;</span>dans<span style="font-weight:600">&nbsp;</span>les<span style="font-weight:600">&nbsp;</span>coliques<span style="font-weight:600">&nbsp;</span>et<span style="font-weight:600">&nbsp;</span>colites<span style="font-weight:600">&nbsp;</span>diverses...<span style="font-weight:600">&nbsp;			</span>Eviter<span style="font-weight:600">&nbsp;</span>Viscéralgine<span style="font-weight:600">&nbsp;</span>(effet<span style="font-weight:600">&nbsp;</span>atropinique)<br /><span style="font-weight:600">	3)&nbsp;Les&nbsp;anticomitiaux&nbsp;(Rivotril)&nbsp;et&nbsp;les&nbsp;antidepresseurs&nbsp;(Laroxyl&nbsp;</span>25)<span style="font-weight:600">&nbsp;</span>:&nbsp;<span style="font-style:italic">à&nbsp;</span>utiliser<span style="font-weight:600">&nbsp;			</span>pour<span style="font-weight:600">&nbsp;</span>les&nbsp;douleurs<span style="font-weight:600">&nbsp;</span>de<span style="font-weight:600">&nbsp;</span>désaférentation.<br /><span style="font-weight:600">	4)&nbsp;Xylocaïne&nbsp;</span>:&nbsp;injectable,<span style="font-weight:600">&nbsp;</span>spray,<span style="font-weight:600">&nbsp;</span>gel,<span style="font-weight:600">&nbsp;</span>EMLA,<span style="font-weight:600">&nbsp;</span>Bloc<span style="font-weight:600">&nbsp;</span>Fémoral<span style="font-weight:600">&nbsp;</span>:&nbsp;à&nbsp;utiliser<span style="font-weight:600">&nbsp;</span>pour<span style="font-weight:600">&nbsp;</span>les<span style="font-weight:600">&nbsp;</span>gestes<span style="font-weight:600">&nbsp;			</span>locaux,&nbsp;éventuellement<span style="font-weight:600">&nbsp;</span>associée<span style="font-weight:600">&nbsp;</span>aux<span style="font-weight:600">&nbsp;</span>antalgiques<span style="font-weight:600">&nbsp;</span>et<span style="font-weight:600">&nbsp;</span>à&nbsp;I'Entonox.<span style="font-weight:600">&nbsp;			</span>Xylocaïne:<span style="font-weight:600">&nbsp;</span>Ne<span style="font-weight:600">&nbsp;</span>pas<span style="font-weight:600">&nbsp;</span>dépasser<span style="font-weight:600">&nbsp;5&nbsp;mg/kg&nbsp;</span>(1,5&nbsp;flacon<span style="font-weight:600">&nbsp;</span>à&nbsp;1%).<br />	<span style="font-weight:600">5)&nbsp;Entonox&nbsp;:&nbsp;</span>(Cf<span style="font-weight:600">&nbsp;</span>fiche<span style="font-weight:600">&nbsp;</span>ENTONOX)<br /><br /><span style="font-weight:600">SAU&nbsp;NORD&nbsp;Novembre&nbsp;1999</span><br /></p>
</body></html>
